Invivyd (IVVD) Assets Average (2021 - 2025)
Invivyd (IVVD) reported Assets Average of $208.0 million for Q4 2025, up 42.76% on a YoY basis from $145.7 million in Q4 2024, and up 82.24% quarter-over-quarter from $114.1 million in Q3 2025.
Invivyd (IVVD) Assets Average (2021 - 2025) Analysis & Trends
Invivyd has reported Assets Average for 5 years, with the latest figure at $208.0 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 42.76% year-over-year to $208.0 million; the trailing twelve-month figure through Dec 2025 stood at $208.0 million (up 42.76% YoY), and the FY2025 full-year result was $203.2 million, up 13.3% from the prior year.
- Assets Average for Q4 2025 stood at $208.0 million, up from $114.1 million in the prior quarter.
- The five-year high for Assets Average was $653.2 million in Q4 2021, with the low at $96.4 million in Q2 2025.
- Historically, Assets Average has averaged $315.5 million across 5 years, with a median of $273.6 million in 2023.
- The largest YoY upside for Assets Average was 42.76% in 2025 against a maximum downside of 50.9% in 2025.
- Invivyd's Assets Average stood at $653.2 million in 2021, then plunged by 38.16% to $404.0 million in 2022, then plunged by 37.6% to $252.0 million in 2023, then plunged by 42.19% to $145.7 million in 2024, then surged by 42.76% to $208.0 million in 2025.
- The last three Assets Average figures came in at $208.0 million (Q4 2025), $114.1 million (Q3 2025), and $96.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 208.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 208.02 Mn |
| Sep 30, 2025 | 114.15 Mn |
| Jun 30, 2025 | 96.44 Mn |
| Mar 31, 2025 | 116.63 Mn |
| Dec 31, 2024 | 145.72 Mn |
| Sep 30, 2024 | 169.63 Mn |
| Jun 30, 2024 | 196.41 Mn |
| Mar 31, 2024 | 222.32 Mn |
| Dec 31, 2023 | 252.05 Mn |
| Sep 30, 2023 | 295.17 Mn |
| Jun 30, 2023 | 332.99 Mn |
| Mar 31, 2023 | 366.87 Mn |
| Dec 31, 2022 | 403.96 Mn |
| Sep 30, 2022 | 454.68 Mn |
| Jun 30, 2022 | 520.44 Mn |
| Mar 31, 2022 | 588.18 Mn |
| Dec 31, 2021 | 653.18 Mn |
| Sep 30, 2021 | 542.13 Mn |